Neogenomics (NEO) Total Non-Current Liabilities (2012 - 2026)

Neogenomics (NEO) has reported Total Non-Current Liabilities for 15 consecutive years, with $433.2 million the latest figure, recorded in Q1 2026.

• Total Non-Current Liabilities for Q1 2026 came in at $433.2 million, changed 0.07% year-over-year; the trailing twelve-month figure through Mar 2026 was $433.2 million (changed 0.07% YoY), and the FY2025 annual result was $435.0 million, changed 0.12% from the prior year.
• Total Non-Current Liabilities was $433.2 million for Q1 2026 at Neogenomics, roughly flat from $435.0 million in the prior quarter.
• Over five years, Total Non-Current Liabilities peaked at $672.5 million in Q1 2022 and troughed at $433.2 million in Q1 2026.
• Average Total Non-Current Liabilities over 5 years is $550.0 million, with a median of $637.9 million recorded in 2023.
• Year-over-year, Total Non-Current Liabilities advanced 15.36% in 2022 and slumped 32.47% in 2024.
• Over 5 years, Total Non-Current Liabilities stood at $652.1 million in 2022, then declined by 1.33% to $643.4 million in 2023, then plunged by 32.47% to $434.5 million in 2024, then increased by 0.12% to $435.0 million in 2025, then dropped by 0.41% to $433.2 million in 2026.
• Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $433.2 million in Q1 2026, $435.0 million in Q4 2025, and $438.6 million in Q3 2025.